trial not randomized double blinded placebo controlled combination considered gold standard clinical research participants continued immune system modulating therapies known reduce symptoms case ms disorders difficulty knowing treatment work effect study compounded erratic nature disease common form relapse remitting ms variable course marked flare ups amid symptom free periods difficult know certain treatment actually works simply taken naturally occurring remission patients taking placebo reported substantial improvements according mount sinai miller furthermore ultimate cause disease remains obscure makes hard gage appropriateness intervention agrees ms destroys fatty myelin sheath enwraps nerve fibers stripped insulation wires nervous system lose ability transmit electrical signals